Synopsys Stock Issuance Proceeds decreased by 85.9% to $12.74M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.6%, from $14.42M to $12.74M. Over 4 years (FY 2021 to FY 2025), Stock Issuance Proceeds shows relatively stable performance with a 2.0% CAGR.
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Standard for large-cap companies with significant equity-based compensation programs.
proceeds_from_stock_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $88.11M | $10.77M | $96.74M | $30.84M | $89.88M | $40.71M | $76.54M | $22.34M | $110.47M | $32.03M | $88.15M | $9.48M | $105.63M | $28.04M | $89.06M | $14.42M | $103.89M | $19.79M | $90.32M | $12.74M |
| QoQ Change | — | -87.8% | +798.0% | -68.1% | +191.5% | -54.7% | +88.0% | -70.8% | +394.5% | -71.0% | +175.2% | -89.2% | >999% | -73.5% | +217.7% | -83.8% | +620.6% | -80.9% | +356.3% | -85.9% |
| YoY Change | — | — | — | — | +2.0% | +277.9% | -20.9% | -27.6% | +22.9% | -21.3% | +15.2% | -57.5% | -4.4% | -12.5% | +1.0% | +52.0% | -1.6% | -29.4% | +1.4% | -11.6% |